Indeterminate cell histiocytosis successfully treated with ultraviolet B phototherapy

M Ishibashi1, T Ouchi, A Tanikawa

  • 1Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. ishibashi@saichu.jp

Insights

Indeterminate cell histiocytosis (ICH) is a rare skin disorder. Broadband ultraviolet B (UVB) phototherapy showed significant effectiveness in treating skin lesions associated with ICH.

Area of Science:

  • Dermatology
  • Oncology
  • Histiocytosis

Background:

  • Indeterminate cell histiocytosis (ICH) is a rare neoplastic disorder.
  • Characterized by skin infiltration of neoplastic cells positive for S-100 and CD1a.
  • ICH cells typically lack Birbeck's granules.

Observation:

  • A 75-year-old male presented with a 4-year history of multiple skin papules.
  • Skin biopsy confirmed dense infiltration of histiocytic cells (CD1a+/S100+).
  • No systemic abnormalities were detected via CT, gallium scintigraphy, or abdominal sonography.

Findings:

  • Broadband ultraviolet B (UVB) therapy was administered for the skin lesions.
  • UVB treatment resulted in partial to almost complete remission of ICH skin lesions.
  • This case highlights a potential therapeutic option for ICH.

Implications:

  • Broadband ultraviolet B (UVB) phototherapy may be a viable treatment for Indeterminate cell histiocytosis.
  • Further research into phototherapy for rare histiocytic disorders is warranted.
  • This finding could offer a less invasive treatment approach for ICH patients.